Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Common and specific proteins and pathways in heart and cerebral ischemia

  • Palà, Elena
  • García-Rodríguez, Paula
  • Bustamante, Alejandro
  • Penalba, Anna
  • Lamana-Vallverdú, Marcel
  • Guamán-Pilco, Daisy R.
  • Delgado, Pilar
  • Riba, Iolanda
  • Jiménez-Balado, Joan
  • Planas, Alejandra
  • Simó-Servat, Olga
  • Escudero-Martínez, Irene
  • Montaner, Joan
[Objective] To understand the similarities and differences between acute ischemic stroke and acute myocardial infarction (AMI) to help in the development of specific or common treatment strategies., [Methods] Using an aptamer-based proteomic array, we measured and compared 1310 circulating proteins in the blood of 40 patients with AIS, 9 patients with AMI, and 31 healthy controls. Pathway enrichment analysis was performed using GSEA and g:profiler., [Results] Ninety-four proteins were differentially expressed in AIS, and 284 were differentially expressed in AMI. Of these, 8 were specific to cerebral ischemia, and 197 were specific to myocardial infarction. Forty-two proteins were altered in both ischemia processes. Most altered pathways in AIS could be classified as immune response, cell cycle processing, molecular transport, or signaling. Pathways altered in AMI were mostly related to lipid metabolism and transport, highlighting cholesterol metabolic processes and estrogen signaling. In both types of ischemia, we found pathways related to metabolism, specifically purine metabolism, and signaling processes, such as TNF signaling or MAPK1/3., [Conclusions] The present study revealed proteins and pathways that were specifically altered in cerebral ischemia, in cardiac ischemia, or in both diseases, providing information on the similarities and differences of ischemic conditions. The role of common and specific proteins and pathways should be explored in detail to find possible therapeutic targets., This work was supported by the Instituto de Salud Carlos III (PI18/00804). The Neurovascular research laboratory is part of the Spanish stroke research RICORS (RD16/0019/00021). Also, part of the authors was funded by the European Union's Horizon 2020 research and innovation program (grant agreements 847770, 754517, and 733379). Also, the funding of the studies from which patients were used are detailed: PRECISED study was supported by an Integrative Excellence Project by the Spanish Institute of Health, Instituto de Salud Carlos III, grant PIE 2013/27, CIBER CV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares), CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas asociadas), and the European Regional Development Fund (ERDF- FEDER); PARIAS study was funded by the Spanish Ministry of Economy, Industry and Competitiveness (Grant RTC-2016-5300-1), the Junta de Andalucía (Grant PIN- 0144-2016), the European Project ITRIBIS, and the Fundación Cajasol; COMBAT-MI was sponsored with a Grant from Instituto de Salud Carlos III (PIE 13/00027), and a Grant from Generalitat de Catalunya (PERIS SLT/2381/2016)., Peer reviewed